Citations (177)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Jickky Palmae Sarathy, Courtney C. Aldrich, Mei-Lin Go & Thomas Dick. (2023) PROTAC antibiotics: the time is now. Expert Opinion on Drug Discovery 18:4, pages 363-370.
Read now
Read now
Onwipa Rochanathimoke, Pramote Tragulpiankit, Saowalak Turongkaravee, Jiraphun Jittikoon, Wanvisa Udomsinprasert & Usa Chaikledkeaw. (2022) Costs Associated with Adverse Drug Reactions Among HIV/TB Patients in Thailand. ClinicoEconomics and Outcomes Research 14, pages 587-599.
Read now
Read now
James C. Johnston, Ryan Cooper & Dick Menzies. (2022) Chapter 5: Treatment of tuberculosis disease. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 6:sup1, pages 66-76.
Read now
Read now
Ilaria Testi, Bjorn Betzler, Vishali Gupta, Onn Min Kon, Rupesh Agrawal & Carlos Pavesio. (2020) Current clinical management of ocular tuberculosis. Expert Review of Ophthalmology 15:2, pages 93-99.
Read now
Read now
Kai Berkenfeld, Jason T. McConville & Alf Lamprecht. (2020) Inhalable dry powders of rifampicin highlighting potential and drawbacks in formulation development for experimental tuberculosis aerosol therapy. Expert Opinion on Drug Delivery 17:3, pages 305-322.
Read now
Read now
Amarsinh R. Deshmukh, Sambhaji T. Dhumal, Laxman U. Nawale, Vijay M. Khedkar, Dhiman Sarkar & Ramrao A. Mane. (2019) Dicationic liquid mediated synthesis of tetrazoloquinolinyl methoxy phenyl 4-thiazolidinones and their antibacterial and antitubercular evaluation. Synthetic Communications 49:4, pages 587-601.
Read now
Read now
Yi-Hsing Chen, Hellen MDS de Carvalho, Umut Kalyoncu, Lyndon John Q Llamado, Gaston Solano, Ron Pedersen, Galina Lukina, Juan J Lichauco & Radu S Vasilescu. (2018) Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice. Biologics: Targets and Therapy 12, pages 1-9.
Read now
Read now
Marcus Ang, Daniel V. Vasconcelos-Santos, Kusum Sharma, Massimo Accorinti, Aman Sharma, Amod Gupta, Narsing A. Rao & Soon-Phaik Chee. (2018) Diagnosis of Ocular Tuberculosis. Ocular Immunology and Inflammation 26:2, pages 208-216.
Read now
Read now
Wassilis SC Bruins & Frank van Leth. (2017) Effect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review. Infectious Diseases 49:3, pages 161-169.
Read now
Read now
Ning-Kui Niu, Juan-Juan Yin, Yin-Xue Yang, Zi-Li Wang, Zhi-Wei Zhou, Zhi-Xu He, Xiao-Wu Chen, Xueji Zhang, Wei Duan, Tianxin Yang & Shu-Feng Zhou. (2015) Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study. Drug Design, Development and Therapy 9, pages 4441-4470.
Read now
Read now
TA Jackson & JM Thomas. (2013) Tuberculosis: the implications for anaesthesia. Southern African Journal of Anaesthesia and Analgesia 19:6, pages 301-305.
Read now
Read now
Rannakoe J Lehloenya & Keertan Dheda. (2012) Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future. Expert Review of Anti-infective Therapy 10:4, pages 475-486.
Read now
Read now
Eva Salgado & Juan J Gómez-Reino. (2011) The risk of tuberculosis in patients treated with TNF antagonists. Expert Review of Clinical Immunology 7:3, pages 329-340.
Read now
Read now
Daniel V. Vasconcelos-Santos, Manfred Zierhut & Narsing A. Rao. (2009) Strengths and Weaknesses of Diagnostic Tools for Tuberculous Uveitis. Ocular Immunology and Inflammation 17:5, pages 351-355.
Read now
Read now
Articles from other publishers (163)
Lufina Tsirizani Galileya, Roeland E. Wasmann, Chishala Chabala, Helena Rabie, Janice Lee, Irene Njahira Mukui, Anneke Hesseling, Heather Zar, Rob Aarnoutse, Anna Turkova, Diana Gibb, Mark F. Cotton, Helen McIlleron & Paolo Denti. (2023) Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis. PLOS Medicine 20:11, pages e1004303.
Crossref
Crossref
Eliz Achhami, Seshkanta Lamichhane, Satyam Mahaju, Ashim Kandel, Anubhav Poudel & Rabina KC. (2023) Unregulated medication use and complications: a case study of prolonged self-treated tuberculosis in Nepal. BMC Infectious Diseases 23:1.
Crossref
Crossref
Jirarat Chongboonwatana, Varalee Terbsiri & Gompol Suwanpimolkul. (2023) Prevalence, risk factors and treatment outcomes of fluoroquinolones-associated tendinopathy in tuberculosis patients at university hospital, Thailand. Heliyon 9:10, pages e20331.
Crossref
Crossref
Renu Gavadia, Jyoti Rasgania, Mandira Varma Basil, Varsha Chauhan, Sanjay Kumar & Komal Jakhar. (2023) Synthesis of isoniazid analogs with promising antituberculosis activity and bioavailability: Biological evaluation and computational studies. Journal of Molecular Structure 1283, pages 135325.
Crossref
Crossref
Saloni Yadav, Aastha Soni, Omprakash Tanwar, Rajendra Bhadane, Gurdyal S. Besra & Neha Kawathekar. (2023) DprE1 Inhibitors: Enduring Aspirations for Future Antituberculosis Drug Discovery. ChemMedChem.
Crossref
Crossref
Nkiruka C. Azubuike, Hilary Obiazikwor, Cornelius O. Ogu, Mariah C. Ugwuodo & Kamsoluchi M. Azubuike. (2023) Comparative in vivo Evaluation of Rat Liver and Kidney Histomorphology Following Treatments with Doxorubicin, Acetaminophen and Anti-Tubercular Drugs. Journal of Pharmacology and Toxicology 18:3, pages 139-149.
Crossref
Crossref
T. Soda, Y. Tashiro, S. Koike, R. Ikeuchi & T. Okada. (2023) Evaluation of incidence, predictive factors and treatment considerations for asymptomatic genitourinary granulomas after intravesical bacillus Calmette-Guérin therapy. Actas Urológicas Españolas (English Edition) 47:5, pages 317-326.
Crossref
Crossref
T. Soda, Y. Tashiro, S. Koike, R. Ikeuchi & T. Okada. (2023) Evaluación de la incidencia, factores predictivos y consideraciones sobre el tratamiento de los granulomas genitourinarios asintomáticos después de la terapia intravesical con bacilo de Calmette-Guérin. Actas Urológicas Españolas 47:5, pages 317-326.
Crossref
Crossref
Alemayehu Lelisa Duga, Francesco Salvo, Alexander Kay & Albert Figueras. (2023) Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase®). Antibiotics 12:5, pages 811.
Crossref
Crossref
Chia-Hao Chang, Lih-Yu Chang, Jen-Chung Ko, Yueh-Feng Wen, Chien-Jen Chang, Li-Ta Keng, Ping-Hsien Tsou, Kai-Lun Yu, Jann-Yuan Wang & Chong-Jen Yu. (2023) Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature Review. Infectious Diseases and Therapy 12:3, pages 919-931.
Crossref
Crossref
Flávia M. Sant´Anna, Mariana Araújo-Pereira, Carolina A. S. Schmaltz, María B. Arriaga, Bruno B. Andrade & Valeria C. Rolla. (2023) Impact of adverse drug reactions on the outcomes of tuberculosis treatment. PLOS ONE 18:2, pages e0269765.
Crossref
Crossref
Kristián Pršo, Nela Žideková, Igor Porvazník, Ivan Solovič, Juraj Mokrý & Martin Kertys. (2022) A high‐throughput LC–MS/MS method for simultaneous determination of isoniazid, ethambutol and pyrazinamide in human plasma. Rapid Communications in Mass Spectrometry 37:2.
Crossref
Crossref
Christoffel Johannes Opperman, Justyna Wojno, Wynand Goosen & Rob Warren. 2023. Phage Therapy - Part B. Phage Therapy - Part B
41
92
.
Silvia S. Chiang & Jeffrey R. Starke. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
806
823.e4
.
Nguyen Ky Anh, Pham My Tung, Min Jung Kim, Nguyen Phuoc Long, Yong-Soon Cho, Dong-Hyun Kim & Jae-Gook Shin. (2022) Quantitative Analysis of Isoniazid and Its Four Primary Metabolites in Plasma of Tuberculosis Patients Using LC-MS/MS. Molecules 27:23, pages 8607.
Crossref
Crossref
Beatriz Barreto-Duarte, Mariana Araújo-Pereira, João P. Miguez-Pinto, Isabella B. B. Ferreira, Rodrigo C. Menezes, Gabriela L. Rosier, Caian L. Vinhaes, Mateus Maggitti-Bezerril, Klauss Villalva-Serra & Bruno B. Andrade. (2022) Grand challenges in major tropical diseases. Frontiers in Tropical Diseases 3.
Crossref
Crossref
Xiangwen Shi, Yipeng Wu, Haonan Ni, Xi Chen & Yongqing Xu. (2022) Comparing the efficacy of different antibiotic regimens on osteomyelitis: A network meta-analysis of animal studies. Frontiers in Medicine 9.
Crossref
Crossref
Koji Kuronuma, Natsumi Susai, Tomohiro Kuroita, Hiroki Yamamoto, Takeshi Yoshioka, Shuji Kaneko & Hirofumi Chiba. (2022) Analysis of real-world data and a mouse model indicates that pirfenidone causes pellagra. ERJ Open Research 8:4, pages 00245-2022.
Crossref
Crossref
Xiaoqun Xu, Houyong Zhu, Long Cai, Libin Liu, Fengwei Zhang, Hongjuan Zhou, Bin Mei, Mingzhi Zhu, Lingshan Dai, Tielong Chen & Kan Xu. (2022) Risk Assessment of Major Adverse Cardiovascular and Cerebrovascular Events and Bleeding for Acute Myocardial Infarction With or Without Active Tuberculosis. Clinical Therapeutics 44:10, pages 1370-1379.
Crossref
Crossref
Niti Singh, Nishant Sharma, Padam Singh, Manitosh Pandey, Mohd Ilyas, Lovely Sisodiya, Tejaswini Choudhury, Tannu Priya Gosain, Ramandeep Singh & Krishnamohan Atmakuri. (2022) HupB, a nucleoid-associated protein, is critical for survival of Mycobacterium tuberculosis under host-mediated stresses and for enhanced tolerance to key first-line antibiotics. Frontiers in Microbiology 13.
Crossref
Crossref
Alexandra J. Zimmer, César Ugarte-Gil, Rahul Pathri, Puneet Dewan, Devan Jaganath, Adithya Cattamanchi, Madhukar Pai & Simon Grandjean Lapierre. (2022) Making cough count in tuberculosis care. Communications Medicine 2:1.
Crossref
Crossref
Javed Akhtar, Sarvesh Singh, Ajay Kumar Verma, Rishi Pal & Rajendra Nath. (2022) A prospective observational study to evaluate Glutathione S-transferase gene polymorphism and its association with Antitubercular drugs induced liver injury in tertiary hospital. Indian Journal of Tuberculosis 69:3, pages 341-346.
Crossref
Crossref
Habib Mahdi & Aleksandar Jovanović. (2022) SUR2A as a base for cardioprotective therapeutic strategies. Molecular Biology Reports 49:7, pages 6717-6723.
Crossref
Crossref
Lujie Liang, Daixi Lin, Yishen Chen, Jiachen Li, Wanfei Liang, Hui Zhao, Wenji Luo, Guo-bao Tian & Siyuan Feng. (2022) Single-Fluorescence ATP Sensor Based on Fluorescence Resonance Energy Transfer Reveals Role of Antibiotic-Induced ATP Perturbation in Mycobacterial Killing. mSystems 7:3.
Crossref
Crossref
Asif Massud, Syed Azhar Syed Sulaiman, Nafees Ahmad, Muhammad Shafqat, Long Chiau Ming & Amer Hayat Khan. (2022) Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study. Frontiers in Pharmacology 13.
Crossref
Crossref
Nur Farhana Mohamed Noor, Mohd Zaki Salleh, Mohd Arif Mohd Zim, Zamzurina Abu Bakar, Mohd Nur Fakhruzzaman Noorizhab, Noor Izyani Zakaria, Muhammad Imran Lailanor & Lay Kek Teh. (2022)
NAT2
polymorphism and clinical factors that increase antituberculosis drug-induced hepatotoxicity
. Pharmacogenomics 23:9, pages 531-541.
Crossref
Crossref
Carolina Castañeda-Fernandez, Rosa María Chávez-Santos, Mayra Silva-Miranda, Clara Espitia-Pinzón, Roberto Martínez & Anna Kozina. (2022) Optimization of rifampicin encapsulation in PLGA polymeric reservoirs. International Journal of Pharmaceutics 622, pages 121844.
Crossref
Crossref
Ayodeji Oluwabunmi Oriola & Adebola Omowunmi Oyedeji. (2022) Plant-Derived Natural Products as Lead Agents against Common Respiratory Diseases. Molecules 27:10, pages 3054.
Crossref
Crossref
Dharini BoopathiAkshatha J SUma BuggiHema SivaArun K PDeepalakshmi Mani. (2022) Analysis of Adverse Drug Reactions associated with Anti-tubercular drugs – A Retrospective Study. Research Journal of Pharmacy and Technology, pages 1483-1486.
Crossref
Crossref
Susai Natsumi, Tomohiro Kuroita, Tatsuru Ishikawa, Koji Kuronuma & Takeshi Yoshioka. (2021) Effect of niacin supplementation on nausea-like behaviour in an isoniazid-induced mouse model of pellagra. British Journal of Nutrition 127:7, pages 961-971.
Crossref
Crossref
William Hywel Bermingham, Rashmeet Bhogal, Sowmya Arudi Nagarajan, Leman Mutlu, Reham Mohamed El‐Shabrawy, Ramesh Madhan, Uma Maheswari Krishnaswamy, Mandakolathur Ramaswamy Murali, Sanath Thushara Kudagammana, Rajeev Shrestha, Stevent Sumantri, Devasahayam Jesudas Christopher, Padukudru Anand Mahesh, Martin Dedicoat & Mamidipudi Thirumala Krishna. (2022) Practical management of suspected hypersensitivity reactions to anti‐tuberculosis drugs. Clinical & Experimental Allergy 52:3, pages 375-386.
Crossref
Crossref
Jacqueline V. Lara-Espinosa, María Fernanda Arce-Aceves, Manuel O. López-Torres, Vasti Lozano-Ordaz, Dulce Mata-Espinosa, Jorge Barrios-Payán, Carlos Alfredo Silva-Islas, Perla D. Maldonado, Brenda Marquina-Castillo & Rogelio Hernández-Pando. (2022) Effect of Curcumin in Experimental Pulmonary Tuberculosis: Antimycobacterial Activity in the Lungs and Anti-Inflammatory Effect in the Brain. International Journal of Molecular Sciences 23:4, pages 1964.
Crossref
Crossref
Pallavi Raj Sharma, Ameya Atul Dravid, Yeswanth Chakravarthy Kalapala, Vishal K. Gupta, Sharumathi Jeyasankar, Avijit Goswami & Rachit Agarwal. (2022) Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages. Biomaterials Advances 133, pages 112612.
Crossref
Crossref
Summaya Perveen, Diksha Kumari, Kuljit Singh & Rashmi Sharma. (2022) Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance. European Journal of Medicinal Chemistry 229, pages 114066.
Crossref
Crossref
Flávia M. Sant´Anna, Mariana Araújo-Pereira, Carolina A. S. Schmaltz, María B. Arriaga, Raquel V. C. de Oliveira, Bruno B. Andrade & Valeria C. Rolla. (2022) Adverse Drug Reactions Related to Treatment of Drug-Susceptible Tuberculosis in Brazil: A Prospective Cohort Study. Frontiers in Tropical Diseases 2.
Crossref
Crossref
Jannah Lee S. Tarranza & Maria Carmen D. Ang. (2022) The association of CD4 lymphocyte count with drug hypersensitivity reaction to highly active antiretroviral therapy, trimethoprim sulfamethoxazole, and antitubercular agents in human immunodeficiency virus patients. Asia Pacific Allergy 12:3.
Crossref
Crossref
Bijan Ghassemieh & Masahiro Narita. 2022. Pulmonary Tuberculosis and Its Prevention. Pulmonary Tuberculosis and Its Prevention
217
232
.
Farah Musharbash, Varun Puvanesarajah & Amit Jain. 2022. Tuberculosis of the Spine. Tuberculosis of the Spine
215
222
.
Summaya Perveen & Rashmi Sharma. 2022. Microbiome in Inflammatory Lung Diseases. Microbiome in Inflammatory Lung Diseases
207
226
.
Youjin Yoon, Hoonhee Seo, Sukyung Kim, Youngkyoung Lee, MD Abdur Rahim, Saebim Lee & Ho-Yeon Song. (2021)
Anti-Tuberculosis Activity of
Pediococcus acidilactici
Isolated from Young Radish Kimchi against
Mycobacterium tuberculosis
. Journal of Microbiology and Biotechnology 31:12, pages 1632-1642.
Crossref
Crossref
Yuqing Wu, Guangming Xiao, Peilan Zong, Guoqiang Jiang, Yongmei Liao, Zhou Liu & Yanhong Zhou. (2021) Diagnosis of Hypersensitivity Induced by Antituberculosis Drugs. Journal of Healthcare Engineering 2021, pages 1-5.
Crossref
Crossref
Samreen Fatima, Anjna Kumari & Ved Prakash Dwivedi. (2021) Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals. MedComm 2:4, pages 494-513.
Crossref
Crossref
Hyun Hwa Kim, Mira Moon, Nigh Choi, Dong Yoon Kang, Kyung Ok Chae, Jungsil Lee, Jae-Joon Lim, Sang-Heon Cho & Hye-Ryun Kang. (2021) Adverse Drug Reactions to First-line Anti-tubercular Drugs Based on Individual Case Safety Report in a Single Tertiary Hospital. The Korean Journal of Medicine 96:5, pages 421-431.
Crossref
Crossref
Ankit Balhara & Saranjit Singh. (2021) PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid. Pharmaceutical Research 38:9, pages 1485-1496.
Crossref
Crossref
Aslı Gelincik & Semra Demir. (2021) Hypersensitivity Reactions to Non-Beta Lactam Antibiotics. Current Treatment Options in Allergy 8:3, pages 161-193.
Crossref
Crossref
Mohammad Aqdas, Sanpreet Singh, Mohammed Amir, Sudeep Kumar Maurya, Susanta Pahari & Javed Naim Agrewala. (2021) Cumulative Signaling Through NOD-2 and TLR-4 Eliminates the Mycobacterium Tuberculosis Concealed Inside the Mesenchymal Stem Cells. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Yaru Xing, Lin Yin, Xiaoqin Le, Jun Chen, Lin Zhang, Yingying Li, Hongzhou Lu & Lijun Zhang. (2021) Simultaneous determination of first-line anti-tuberculosis drugs and one metabolite of isoniazid by liquid chromatography/tandem mass spectrometry in patients with human immunodeficiency virus-tuberculosis coinfection. Heliyon 7:7, pages e07532.
Crossref
Crossref
Saifei Lei, Ruizhi Gu & Xiaochao Ma. (2021) Clinical perspectives of isoniazid-induced liver injury. Liver Research 5:2, pages 45-52.
Crossref
Crossref
G. Sousa, A. Carreiro & P. Duarte. (2021) Rifampicin-induced disseminated intravascular coagulation: An antibody-mediated side effect. Pulmonology 27:3, pages 269-272.
Crossref
Crossref
A. A. Kachanova, Yu. A. Pimenova, G. N. Shuev, K. A. Akmalova, Zh. A. Sozaeva, N. M. Krasnova, E. A. Grishina & D. A. Sychev. (2021) Study of the Effect of Polymorphic Markers of the NAT2 Gene on the Risk of Adverse Drug Reactions in Patients with Pulmonary Tuberculosis Who Received Isoniazid and Rifampicin. Safety and Risk of Pharmacotherapy 9:1, pages 25-33.
Crossref
Crossref
Rajendra Prasad, Abhijeet Singh & Nikhil Gupta. (2021) Adverse Drug Reactions with First-Line and Second-Line Drugs in Treatment of Tuberculosis. Annals of the National Academy of Medical Sciences (India) 57:01, pages 15-35.
Crossref
Crossref
Boubacar Traore, Gladys Tsoumbou Bakana, Samira Nani & Samira Hassoune. (2021) Risk Management Assessments of Anti-tuberculosis Adverse Drug Reaction: A Systematic Review. E3S Web of Conferences 319, pages 01042.
Crossref
Crossref
Nitin Dhochak, Kana Ram Jat, Jhuma Sankar, Sushil K. Kabra & Rakesh Lodha. (2020) Hypersensitivity Myocarditis Due to Antitubercular Drugs in Children. Pediatric Infectious Disease Journal 39:12, pages 1088-1091.
Crossref
Crossref
Naasson Tuyiringire, Serawit Deyno, Anke Weisheit, Casim Umba Tolo, Deusdedit Tusubira, Jean-Pierre Munyampundu, Patrick Engeu Ogwang, Claude Mambo Muvunyi & Yvan Vander Heyden. (2020) Three promising antimycobacterial medicinal plants reviewed as potential sources of drug hit candidates against multidrug-resistant tuberculosis. Tuberculosis 124, pages 101987.
Crossref
Crossref
Bijoy Kumar Panda, Medha Bargaje & Sathiyanarayanan L.. (2020) A simple and reliable analytical method for simultaneous quantification of first line antitubercular drugs in human plasma by LCMS/MS. Analytical Methods 12:31, pages 3909-3917.
Crossref
Crossref
K Prso, N Zidekova, M Dohal, I Porvaznik, M Prso, M Kertys & J Mokry. (2020) Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs. Acta Medica Martiniana 20:2, pages 45-55.
Crossref
Crossref
Chunying Zhang, Lin Jiao, Hao Bai, Zhenzhen Zhao, Xuejiao Hu, Minjin Wang, Tao Wu, Wu Peng, Tangyuheng Liu, Jiajia Song, Juan Zhou, Mengjiao Li, Mengyuan Lyv, Jingwei Zhang, Hao Chen, Jie Chen & Binwu Ying. (2020) Association of POR and PPARα polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population. Infection, Genetics and Evolution 79, pages 104147.
Crossref
Crossref
Deepak Kumar, Sukhpreet Singh, Sumanpreet Kaur, Monu Kumari, Rajasri Bhattacharyya & Dibyajyoti Banerjee. (2020) Rifampicin and isoniazid behave as non-creatinine chromogens and interfere with Jaffe's reaction: A phenomenon with the potential to give a false-positive result in creatinine estimation. Indian Journal of Tuberculosis 67:2, pages 253-256.
Crossref
Crossref
Xue-Zhao Yu, Ling-Yang Wang, Fang Liu, Yan-Tuan Li, Zhi-Yong Wu & Cui-Wei Yan. (2020) Sustained-Release Dual-Drug Ternary Salt Cocrystal of Piperazine Ferulate with Pyrazinamide: Synthesis, Structure, and Hirshfeld Surface Analysis. Crystal Growth & Design 20:3, pages 2064-2073.
Crossref
Crossref
Song Lin, Shanliang Zhao, Jiahong Liu, Jianwen Zhang, Chao Zhang, Haibo Hao, Yuxia Sun, Jing Cai, Yang Yang, Yan Ma, Yuanyuan Li, Jinyu Wang & Aiguo Ma. (2020)
Efficacy of proprietary
Lactobacillus casei
for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose–response trial
. Food & Function 11:1, pages 370-377.
Crossref
Crossref
Zhenzhen Zhao, Wu Peng, Lijuan Wu & Binwu Ying. (2020) Correlation between lncRNA AC079767.4 variants and liver injury from antituberculosis treatment in West China. Journal of Infection and Chemotherapy 26:1, pages 63-68.
Crossref
Crossref
Anupam Jyoti, Sanket Kaushik & Vijay Kumar Srivastava. 2020. Molecular Advancements in Tropical Diseases Drug Discovery. Molecular Advancements in Tropical Diseases Drug Discovery
47
63
.
Jinsoo Min, Ju Sang Kim, Hyung Woo Kim, Ah Young Shin, Hyeon-Kyoung Koo, Sung-Soon Lee, Yang-Ki Kim, Kyeong-Cheol Shin, Jung Hyun Chang, Gayoung Chun, Joosun Lee, Mi Sun Park & Jae Seuk Park. (2019) Clinical profiles of early and tuberculosis-related mortality in South Korea between 2015 and 2017: a cross-sectional study. BMC Infectious Diseases 19:1.
Crossref
Crossref
Hiroyuki Nagano, Tomoaki Miura & Takeshi Ueda. (2019) Mania induced by isoniazid preventive therapy during steroid treatment for rheumatoid arthritis and organising pneumonia. BMJ Case Reports 12:11, pages e231919.
Crossref
Crossref
Rajendra Prasad, Abhijeet Singh & Nikhil Gupta. (2019) Adverse drug reactions in tuberculosis and management. Indian Journal of Tuberculosis 66:4, pages 520-532.
Crossref
Crossref
Miaomiao Yang, Haiping Zhang, Bilin Tao, Hongqiu Pan, Lihuan Lu, Honggang Yi & Shaowen Tang. (2019) Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study. Journal of Clinical Pharmacy and Therapeutics 44:4, pages 534-542.
Crossref
Crossref
Edén M. Rodríguez-Flores, Dulce Mata-Espinosa, Jorge Barrios-Payan, Brenda Marquina-Castillo, Mauricio Castañón-Arreola & Rogelio Hernández-Pando. (2019) A significant therapeutic effect of silymarin administered alone, or in combination with chemotherapy, in experimental pulmonary tuberculosis caused by drug-sensitive or drug-resistant strains: In vitro and in vivo studies. PLOS ONE 14:5, pages e0217457.
Crossref
Crossref
Elham Nemati, Ahad Mokhtarzadeh, Vahid Panahi-Azar, Ali Mohammadi, Hamed Hamishehkar, Mehran Mesgari-Abbasi, Jafar Ezzati Nazhad Dolatabadi & Miguel de la Guardia. (2019) Ethambutol-Loaded Solid Lipid Nanoparticles as Dry Powder Inhalable Formulation for Tuberculosis Therapy. AAPS PharmSciTech 20:3.
Crossref
Crossref
Hyo-Ji Lee, Hyun-Jeong Ko, Seung Hyun Kim & Yu-Jin Jung. (2019) Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages. PLOS ONE 14:3, pages e0199799.
Crossref
Crossref
Qian Lei, Hao Wang, Yuan Zhao, Liyun Dang, Changsheng Zhu, Xiaohui Lv, Hui Wang & Jun Zhou. (2019) Determinants of serum concentration of first-line anti-tuberculosis drugs from China. Medicine 98:41, pages e17523.
Crossref
Crossref
John Koech Kipsang, Joseph K. Choge, Pamela A. Marinda & Christopher Khayeka-Wandabwa. (2019) Pellagra in isoniazid preventive and antiretroviral therapy. IDCases 17, pages e00550.
Crossref
Crossref
Swapnil Yeshwant Parab & Sheila Nainan Myatra. 2019. Principles and Practice of Anesthesia for Thoracic Surgery. Principles and Practice of Anesthesia for Thoracic Surgery
699
716
.
Su-Tso Yang, Yi-Rong Lin, Mei-Yao Wu, Jen-Huai Chiang, Pei-Shan Yang, Te-Chun Hsia & Hung-Rong Yen. (2018) Utilization of Chinese medicine for respiratory discomforts by patients with a medical history of tuberculosis in Taiwan. BMC Complementary and Alternative Medicine 18:1.
Crossref
Crossref
Haiping Zhang, Haisheng Qian, Bilin Tao, Miaomiao Yang, Jingye Gong, Honggang Yi & Shaowen Tang. (2018) The association between BACH1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort. Infection, Genetics and Evolution 66, pages 217-221.
Crossref
Crossref
Ling-Yu Ruan, Jun-Ting Fan, Wei Hong, He Zhao, Ming-Hui Li, Lei Jiang, Yong-Hong Fu, Yue-Xiao Xing, Cheng Chen & Jun-Song Wang. (2018) Isoniazid-induced hepatotoxicity and neurotoxicity in rats investigated by 1H NMR based metabolomics approach. Toxicology Letters 295, pages 256-269.
Crossref
Crossref
Xuejiao Hu, Mei Zhang, Hao Bai, Lijuan Wu, Yanqing Chen, Liu Ding, Zhenzhen Zhao, Wu Peng, Tangyuheng Liu, Jiajia Song, Yinyu Li, Xiaojun Lu, Xuerong Chen, Yanhong Zhou & Binwu Ying. (2018) Antituberculosis Drug-Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic Predictors. Clinical Pharmacology & Therapeutics 104:2, pages 326-334.
Crossref
Crossref
Shouhong Gao, Zhipeng Wang, Xinfang Xie, Chunhua You, Yang Yang, Yanhai Xi & Wansheng Chen. (2018) Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring. Tuberculosis 109, pages 28-34.
Crossref
Crossref
Susanta Pahari, Gurpreet Kaur, Shikha Negi, Mohammad Aqdas, Deepjyoti K. Das, Hilal Bashir, Sanpreet Singh, Mukta Nagare, Junaid Khan & Javed N. Agrewala. (2018) Reinforcing the Functionality of Mononuclear Phagocyte System to Control Tuberculosis. Frontiers in Immunology 9.
Crossref
Crossref
Silvia S. Chiang & Jeffrey R. Starke. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
790
806.e5
.
Sarah D. Kowitt, Hairong Nan & Jane Speight. 2018. Principles and Concepts of Behavioral Medicine. Principles and Concepts of Behavioral Medicine
987
1019
.
Yuan-Qiang Hu, Xu-Feng Song & Jing Fan. (2018)
Design, Synthesis, and
in vitro
Antimycobacterial Activity of Propylene-tethered Isatin Dimmers
. Journal of Heterocyclic Chemistry 55:1, pages 265-268.
Crossref
Crossref
Hsiao-Yun Chang, Chao-Jung Chen, Wei-Chih Ma, Wai-Kok Cheng, Yen-Ning Lin, Ying-Ray Lee, Jih-Jung Chen & Yun-Ping Lim. (2017) Modulation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation by ursolic acid (UA) attenuates rifampin-isoniazid cytotoxicity. Phytomedicine 36, pages 37-49.
Crossref
Crossref
Shachi Pranjal Vyas & Ritobrata Goswami. (2017) Striking the right immunological balance prevents progression of tuberculosis. Inflammation Research 66:12, pages 1031-1056.
Crossref
Crossref
Yen-Ning Lin, Chao-Jung Chen, Hsiao-Yun Chang, Wai-Kok Cheng, Ying-Ray Lee, Jih-Jung Chen & Yun-Ping Lim. (2017) Oleanolic Acid-Mediated Inhibition of Pregnane X Receptor and Constitutive Androstane Receptor Attenuates Rifampin-Isoniazid Cytotoxicity. Journal of Agricultural and Food Chemistry 65:39, pages 8606-8616.
Crossref
Crossref
Connie A. Haley. 2017. Tuberculosis and Nontuberculous Mycobacterial Infections. Tuberculosis and Nontuberculous Mycobacterial Infections
67
100
.
Jean-Christoph Caubet. (2017) How to Manage Drug-Induced Exanthema in Children. Current Treatment Options in Allergy 4:2, pages 222-238.
Crossref
Crossref
Tume Christopher Bonglavnyuy. (2017) Sero-prevalence of Hepatitis B and C virus and High Risk of Hepatotoxicity among TB/HIV Positive and HIV Negative Population in Western Cameroon. Global Journal of Infectious Diseases and Clinical Research, pages 001-006.
Crossref
Crossref
Christopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, Vijay Ivaturi, Jotam Pasipanodya, Shashikant Srivastava, Chawangwa Modongo, Nicola M. Zetola, Drew Weissman, Tawanda Gumbo & Gregory P. Bisson. (2016) Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activation. British Journal of Clinical Pharmacology 83:4, pages 801-811.
Crossref
Crossref
Connie A. Haley. (2017) Treatment of Latent Tuberculosis Infection. Microbiology Spectrum 5:2.
Crossref
Crossref
Francisco G. Avalos-Alanís, Eugenio Hernández-Fernández, Pilar Carranza-Rosales, Susana López-Cortina, Jorge Hernández-Fernández, Mario Ordóñez, Nancy E. Guzmán-Delgado, Alejandro Morales-Vargas, Víctor M. Velázquez-Moreno & María G. Santiago-Mauricio. (2017) Synthesis, antimycobacterial and cytotoxic activity of α,β-unsaturated amides and 2,4-disubstituted oxazoline derivatives. Bioorganic & Medicinal Chemistry Letters 27:4, pages 821-825.
Crossref
Crossref
Bo Hyoung KangKyung-Wook JoTae Sun Shim. (2017) Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea. Tuberculosis and Respiratory Diseases 80:2, pages 143.
Crossref
Crossref
Marcus Ang & Soon-Phaik Chee. (2017) Controversies in ocular tuberculosis. British Journal of Ophthalmology 101:1, pages 6-9.
Crossref
Crossref
L. Aït Moussa, O. El Bouazzi, S. Serragui, D. Soussi Tanani, A. Soulaymani & R. Soulaymani. (2016) Rifampicin and isoniazid plasma concentrations in relation to adverse reactions in tuberculosis patients: a retrospective analysis. Therapeutic Advances in Drug Safety 7:6, pages 239-247.
Crossref
Crossref
Soukaina GuaouaIlham RatbiOmaima El BouazziSanaa HammiAmina TebaaJamal Eddine BourkadiRachida Soulaymani BencheikhAbdelaziz Sefiani. (2016)
NAT2
Genotypes in Moroccan Patients with Hepatotoxicity Due to Antituberculosis Drugs
. Genetic Testing and Molecular Biomarkers 20:11, pages 680-684.
Crossref
Crossref
Neesha Rockwood, Graeme Meintjes, Maxwell Chirehwa, Lubbe Wiesner, Helen McIlleron, Robert J. Wilkinson & Paolo Denti. (2016) HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients. Antimicrobial Agents and Chemotherapy 60:10, pages 6050-6059.
Crossref
Crossref
Daniel J. Klein, Sotiria Boukouvala, Ellen M. McDonagh, Scott R. Shuldiner, Nicola Laurieri, Caroline F. Thorn, Russ B. Altman & Teri E. Klein. (2016) PharmGKB summary. Pharmacogenetics and Genomics 26:9, pages 436-444.
Crossref
Crossref
Heirim LeeMin-Sun KimHea-Kyoung YangMinji KimJi Young LeeJong-Min KimJi-Man KangYae-Jean KimKangmo AhnJihyun Kim. (2016) Rapid desensitization to isoniazid and rifampin in an adolescent with active pulmonary tuberculosis. Allergy, Asthma & Respiratory Disease 4:3, pages 212.
Crossref
Crossref
Sandra R. Wilson, Meghan Halley & Sarah Knowles. 2016. Health Disparities in Respiratory Medicine. Health Disparities in Respiratory Medicine
105
133
.
Geetha Vani Rayasam & Tanjore S Balganesh. (2015) Exploring the potential of adjunct therapy in tuberculosis. Trends in Pharmacological Sciences 36:8, pages 506-513.
Crossref
Crossref
Tulin Ergun, Dilek Seckin, Emel Baskan Bulbul, Nahide Onsun, Zuleyha Ozgen, Pemra Unalan, Erkan Alpsoy & Sait Karakurt. (2015) The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents. International Journal of Dermatology 54:5, pages 594-599.
Crossref
Crossref
Ana Tavares e Castro, Mariana Mendes, Sara Freitas & Paulo Cravo Roxo. (2015) Incidence and risk factors of major toxicity associated to first-line antituberculosis drugs for latent and active tuberculosis during a period of 10 years. Revista Portuguesa de Pneumologia (English Edition) 21:3, pages 144-150.
Crossref
Crossref
Amandeep Kaur, Bharti Mahajan, Nishit Gupta, Sandeep Kaushal & R.K. Soni. (2015) Adverse drug reactions and risk factor association of antitubercular drugs during intensive phase of DOTS in patients of Northern India. Indian Journal of Medical Specialities 6:2, pages 51-54.
Crossref
Crossref
Mohammed A. Agha, Ibraheim I. El-Mahalawy, Hosam M. Seleem & Mohamed A. Helwa. (2015) Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity. Egyptian Journal of Chest Diseases and Tuberculosis 64:1, pages 91-96.
Crossref
Crossref
Abhijeet Singh, Rajendra Prasad, Viswesvaran Balasubramanian, Nikhil Gupta & Pawan Gupta. (2015) Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis. Clinical Epidemiology and Global Health 3, pages S80-S90.
Crossref
Crossref
James F. Stanford. 2015. Cutaneous Drug Eruptions. Cutaneous Drug Eruptions
397
430
.
Soukaina Guaoua, Ilham Ratbi, Fatima Zahra Laarabi, Siham Chafai Elalaoui, Imane Cherkaoui Jaouad, Amina Barkat & Abdelaziz Sefiani. (2014) Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1variants in Moroccan population. BMC Genetics 15:1.
Crossref
Crossref
H. Daghfous, H. Zaibi & F. Tritar. (2014) Choc anaphylactique aux antituberculeux?: quel bilan et quelle prise en charge??. Revue Fran?aise d'Allergologie 54:8, pages 580-585.
Crossref
Crossref
Christine M. Hunt, Nancy A. Yuen, Heide A. Stirnadel-Farrant & Ayako Suzuki. (2014) Age-related differences in reporting of drug-associated liver injury: Data-mining of WHO Safety Report Database. Regulatory Toxicology and Pharmacology 70:2, pages 519-526.
Crossref
Crossref
Maunank Shah & Caitlin Reed. (2014) Complications of tuberculosis. Current Opinion in Infectious Diseases 27:5, pages 403-410.
Crossref
Crossref
Kuldeep Chauhan, Moni Sharma, Priyanka Trivedi, Vinita Chaturvedi & Prem M.S. Chauhan. (2014) New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents. Bioorganic & Medicinal Chemistry Letters 24:17, pages 4166-4170.
Crossref
Crossref
Ellen M. McDonagh, Sotiria Boukouvala, Eleni Aklillu, David W. Hein, Russ B. Altman & Teri E. Klein. (2014) PharmGKB summary. Pharmacogenetics and Genomics 24:8, pages 409-425.
Crossref
Crossref
Fu-Wei Zhou, Huang-Shu Lei, Li Fan, Li Jiang, Jian Liu, Xin-Mei Peng, Xing-Ran Xu, Li Chen, Cheng-He Zhou, Yan-Ye Zou, Cai-Ping Liu, Zhi-Qin He & Da-Cheng Yang. (2014) Design, synthesis, and biological evaluation of dihydroartemisinin?fluoroquinolone conjugates as a novel type of potential antitubercular agents. Bioorganic & Medicinal Chemistry Letters 24:8, pages 1912-1917.
Crossref
Crossref
Bernard Yu-Hor ThongFaith Li-Ann ChiaSze-Chin TanTeck-Choon TanKhai-Pang LeongJustina Wei-Lyn TanChwee-Ying TangJin-Feng HouGrace Yin-Lai ChanHiok-Hee Chng. (2014) A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy. Asia Pacific Allergy 4:3, pages 156.
Crossref
Crossref
Evy YunihastutiAlvina WidhaniTeguh Harjono Karjadi. (2014) Drug hypersensitivity in human immunodeficiency virus-infected patient: challenging diagnosis and management. Asia Pacific Allergy 4:1, pages 54.
Crossref
Crossref
Lauren Walker, Vincent Yip & Munir Pirmohamed. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine
405
435
.
Julianna Cheng, Surabhi Rawal, Ashley Roberts & Orlee R. Guttman. (2013) Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Associated With Antituberculosis Medications. Pediatric Infectious Disease Journal 32:12, pages 1388-1390.
Crossref
Crossref
B. J. Seaworth, L. Y. Armitige & D. E. Griffith. (2013) First Do No Harm--Adverse Events, Drug Intolerance, and Hepatotoxicity: How Can We Not Justify Directly Observed Therapy for Treating Tuberculosis?. Clinical Infectious Diseases 57:7, pages 1063-1064.
Crossref
Crossref
Mauri Monteiro Rodrigues, Ester Nei Aparecida Martins Coletta, Rimarcs Gomes Ferreira & Carlos Alberto de Castro Pereira. (2013) Delayed diagnosis of sarcoidosis is common in Brazil. Jornal Brasileiro de Pneumologia 39:5, pages 539-546.
Crossref
Crossref
Riffat Fatima, Muhammad Ashraf, Sohail Ejaz, Muhammad Adil Rasheed, Imran Altaf, Misbah Afzal, Zainab Batool, Umber Saleem & Khaleeq Anwar. (2013) In vitro toxic action potential of anti tuberculosis drugs and their combinations. Environmental Toxicology and Pharmacology 36:2, pages 501-513.
Crossref
Crossref
D. P. Eisen & J. S. Denholm. (2013) Recommendations for Rifampicin Therapy of Staphylococcal Infection in Infectious Diseases Society of America Prosthetic Joint Infection Guidelines Are Not Supported by Available Literature. Clinical Infectious Diseases 57:1, pages 159-160.
Crossref
Crossref
Mario Sánchez-Borges, Bernard Thong, Miguel Blanca, Luis Felipe Chiaverini Ensina, Sandra González-Díaz, Paul A Greenberger, Edgardo Jares, Young-Koo Jee, Luciana Kase-Tanno, David Khan, Jung-Won Park, Werner Pichler, Antonino Romano & Maria José Torres Jaén. (2013) Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy. World Allergy Organization Journal 6, pages 18.
Crossref
Crossref
Sharel Ongchin, C Dirk Keene, Russell Van Gelder & Gurunadh Atma Vemulakonda. (2013) A diagnostic dilemma: infectious versus noninfectious multifocal choroiditis with panuveitis. Journal of Ophthalmic Inflammation and Infection 3:1, pages 26.
Crossref
Crossref
Harshad Devarbhavi, Rajvir Singh, Mallikarjun Patil, Keyur Sheth, Channagiri Krishnamurthy Adarsh & Girisha Balaraju. (2013) Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury. Journal of Gastroenterology and Hepatology 28:1, pages 161-167.
Crossref
Crossref
Francisco Jose Forestiero, Leticia Cecon, Mario Hirouki Hirata, Fernando Fiuza de Melo, Rosilene Fressatti Cardoso, Alvaro Cerda & Rosario Dominguez Crespo Hirata. (2013) Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy. Clinica Chimica Acta 415, pages 215-219.
Crossref
Crossref
James W. Little, Donald A. Falace, Craig S. Miller & Nelson L. Rhodus. 2013. Little and Falace's Dental Management of the Medically Compromised Patient. Little and Falace's Dental Management of the Medically Compromised Patient
94
118
.
Frances C. Tyrrell, Gary E. Budnick, Thor Elliott, Laura Gillim-Ross, Mary V. Hildred, Peggy Mahlmeister, Nicole Parrish, Michael Pentella, Jolene Vanneste, Yun F. (Wayne) Wang & Angela M. Starks. (2012) Probability of Negative Mycobacterium tuberculosis Complex Cultures Based on Time to Detection of Positive Cultures: a Multicenter Evaluation of Commercial-Broth-Based Culture Systems. Journal of Clinical Microbiology 50:10, pages 3275-3282.
Crossref
Crossref
Neeraj Shakya, Gaurav Garg, Babita Agrawal & Rakesh Kumar. (2012) Chemotherapeutic Interventions Against Tuberculosis. Pharmaceuticals 5:7, pages 690-718.
Crossref
Crossref
Bakshish Singh & Gurpreet Singh. (2011) Uncontrolled blood pressure in tubercular patients on hemodialysis: Think rifampicin. Hemodialysis International 16:2, pages 324-325.
Crossref
Crossref
Michelle Sholzberg, Jay S. Keystone, Wayne L. Gold, Thomas C. Havey & Christine Cserti-Gazdewich. (2012) Recurrent Disseminated Intravascular Coagulation Caused by Intermittent Dosing of Rifampin. The American Journal of Tropical Medicine and Hygiene 86:2, pages 264-267.
Crossref
Crossref
Etienne Mokondjimobe, Benjamin Longo-Mbenza, Jean Akiana, Ulrich Oswald Ndalla, Regis Dossou-Yovo, Joseph Mboussa & Henri-Joseph Parra. (2012) Biomarkers of Oxidative Stress and Personalized Treatment of Pulmonary Tuberculosis: Emerging Role of Gamma-Glutamyltransferase. Advances in Pharmacological Sciences 2012, pages 1-7.
Crossref
Crossref
Jeffrey R. Starke. 2012. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
771
786.e6
.
Sheeba Veluthoor, Preetha Badi, Keya Mukharjee & Vikramjit Mandal. 2012. Bioactive Natural Products. Bioactive Natural Products
417
463
.
R. J. Andrade & P. M. Tulkens. (2011) Hepatic safety of antibiotics used in primary care. Journal of Antimicrobial Chemotherapy 66:7, pages 1431-1446.
Crossref
Crossref
Prithwiraj De, Georges Koumba Yoya, Patricia Constant, Florence Bedos-Belval, Hubert Duran, Nathalie Saffon, Mamadou Daffé & Michel Baltas. (2011) Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents. Journal of Medicinal Chemistry 54:5, pages 1449-1461.
Crossref
Crossref
Sang-Heon Kim, Sang-Hoon Kim, Ho Joo Yoon, Dong Ho Shin, Sung Soo Park, Youn-Seup Kim, Jae-Seuk Park & Young Koo Jee. (2010) NAT2, CYP2C9, CYP2C19, and CYP2E1 genetic polymorphisms in anti-TB drug-induced maculopapular eruption. European Journal of Clinical Pharmacology 67:2, pages 121-127.
Crossref
Crossref
Bernard Yu-Hor Thong. (2011) Clinical applications of drug desensitization in the Asia-Pacific region. Asia Pacific Allergy 1:1, pages 2.
Crossref
Crossref
Ju Seung KimYoung Rock JangJi Won LeeJin Yong KimYoung Kul JungDong Hae ChungOh Sang KwonYun Soo KimDuck Joo ChoiJu Hyun Kim. (2011) A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage. The Korean Journal of Hepatology 17:3, pages 229.
Crossref
Crossref
Lilach Vaks & Itai Benhar. 2011. Biomedical Nanotechnology. Biomedical Nanotechnology
187
206
.
Harshad Devarbhavi, Ross Dierkhising, Walter K Kremers, M S Sandeep, Dheeraj Karanth & C K Adarsh. (2010) Single-Center Experience With Drug-Induced Liver Injury From India: Causes, Outcome, Prognosis, and Predictors of Mortality. American Journal of Gastroenterology 105:11, pages 2396-2404.
Crossref
Crossref
Vicente Giner, Carmen S?nchez, Vanesa Blanes & Mar?a Jos? Esteban. (2010) Encefalopat?a aguda y s?ndrome mononucle?sico tras instauraci?n de quimioprofilaxis antituberculosa. Enfermedades Infecciosas y Microbiolog?a Cl?nica 28:9, pages 657-658.
Crossref
Crossref
Marcos Abdo Arbex, Marília de Castro Lima Varella, Hélio Ribeiro de Siqueira & Fernando Augusto Fiúza de Mello. (2010) Drogas antituberculose: interações medicamentosas, efeitos adversos e utilização em situações especiais - parte 1: fármacos de primeira linha. Jornal Brasileiro de Pneumologia 36:5, pages 626-640.
Crossref
Crossref
Ana Sofia Vilari?a, Nelson Diogo, Mota Andr?Jaime Pina. (2010) Reac??es adversas aos antibacilares em doentes internados: Gravidade e factores de risco. Revista Portuguesa de Pneumologia (English Edition) 16:3, pages 431-451.
Crossref
Crossref
Ana Sofia Vilari?a, Nelson Diogo, Mota Andr?Jaime Pina. (2010) Reac??es adversas aos antibacilares em doentes internados: Gravidade e factores de risco. Revista Portuguesa de Pneumologia 16:3, pages 431-451.
Crossref
Crossref
S. M. Breathnach. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology
1
177
.
Jakob P. Cramer, Ansgar W. Lohse, Gerd D. Burchard, Lutz Fischer, Björn Nashan, Mathias Zimmermann, Andreas Marx & Stefan Kluge. (2010) Low N-acetyltransferase 2 activity in isoniazid-associated acute hepatitis requiring liver transplantation. Transplant International 23:2, pages 231-233.
Crossref
Crossref
J. M. Leitner, W. Graninger & F. Thalhammer. (2010) Hepatotoxicity of Antibacterials: Pathomechanisms and Clinical Data. Infection 38:1, pages 3-11.
Crossref
Crossref
Bernard Yu-Hor Thong. (2010) Update on the Management of Antibiotic Allergy. Allergy, Asthma and Immunology Research 2:2, pages 77.
Crossref
Crossref
Na Guo, Fawziah Marra & Carlo A Marra. (2009) Measuring health-related quality of life in tuberculosis: a systematic review. Health and Quality of Life Outcomes 7:1.
Crossref
Crossref
BOLETTE SOBORG, MORTEN RUHWALD, MERETE LUND HETLAND, SØREN JACOBSEN, AASE BENGAARD ANDERSEN, NILS MILMAN, VIBEKE OSTERGAARD THOMSEN, DORTE VENDELBO JENSEN, ANDERS KOCH, JAN WOHLFAHRT & PERNILLE RAVN. (2009)
Comparison of Screening Procedures for
Mycobacterium tuberculosis
Infection Among Patients with Inflammatory Diseases
. The Journal of Rheumatology 36:9, pages 1876-1884.
Crossref
Crossref
Christopher B. O'Brien. (2009) The Hospitalized Patient with Abnormal Liver Function Tests. Clinics in Liver Disease 13:2, pages 179-192.
Crossref
Crossref
. (2008) Protecting Health Care Workers from Tuberculosis. Journal of Occupational & Environmental Medicine 50:7, pages 852-855.
Crossref
Crossref
A. Gauchon, N. André, A. Rome, C. Lautraite, C. Coze, J.-C. Gentet, J.-C. Dubus & J.-L. Bernard. (2008) Stratégie de prise en charge de contages tuberculeux dans un service d’oncologie-pédiatrique. Archives de Pédiatrie 15:3, pages 236-244.
Crossref
Crossref
Mark H. Kuniholm, Jennifer Mark, Malvina Aladashvili, N. Shubladze, G. Khechinashvili, Tengiz Tsertsvadze, Carlos del Rio & Kenrad E. Nelson. (2008) Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients. International Journal of Infectious Diseases 12:1, pages 51-56.
Crossref
Crossref
Jeffrey R. Starke & Richard F. Jacobs. 2008. Principles and Practice of Pediatric Infectious Disease. Principles and Practice of Pediatric Infectious Disease
770
788
.
Cynthia Ginsberg, Stephanie Brown & Suzanne Walker. 2008. Glycoscience. Glycoscience
1535
1600
.
Matthew E. Falagas, Paraskevi T. Voidonikola & Anna G. Angelousi. (2007) Tuberculosis in patients with systemic rheumatic or pulmonary diseases treated with glucocorticosteroids and the preventive role of isoniazid: a review of the available evidence. International Journal of Antimicrobial Agents 30:6, pages 477-486.
Crossref
Crossref
P. Tattevin. (2007) Le traitement de la tuberculose en 2007. Médecine et Maladies Infectieuses 37:10, pages 617-628.
Crossref
Crossref
Julie E. Polson. (2007) Hepatotoxicity Due to Antibiotics. Clinics in Liver Disease 11:3, pages 549-561.
Crossref
Crossref
Raphael C. Y. Chan, Mamie Hui, Edward W. C. Chan, T. K. Au, Miu L. Chin, Chun K. Yip, Carrie K. W. AuYeang, Christina Y. L. Yeung, Kai M. Kam, Peter C. W. Yip & Augustine F. B. Cheng. (2007) Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. Journal of Antimicrobial Chemotherapy 59:5, pages 866-873.
Crossref
Crossref
Yves L. Janin. (2007) Antituberculosis drugs: Ten years of research. Bioorganic & Medicinal Chemistry 15:7, pages 2479-2513.
Crossref
Crossref
K. Ijaz, P. D. McElroy, J. Jereb, T. R. Navin & K. G. Castro. (2007) Safety of the Rifampin and Pyrazinamide Short-Course Regimen for Treating Latent Tuberculosis Infection. Clinical Infectious Diseases 44:3, pages 464-465.
Crossref
Crossref
Sascha Meyer, Mohammed Ghiath Shamdeen, Jörg Wüllenweber, Mathias Hermann, Sven Gottschling, Tobias Struffert, Ludwig Gortner & Markus Klotz. (2007) Simultaneous tuberculous meningoencephalitis in two siblingsGleichzeitig auftretende tuberkulöse Meningoencephalitis bei zwei Geschwistern. Wiener Medizinische Wochenschrift 157:1-2, pages 37-42.
Crossref
Crossref
Iftach Yacoby, Marina Shamis, Hagit Bar, Doron Shabat & Itai Benhar. (2006) Targeting Antibacterial Agents by Using Drug-Carrying Filamentous Bacteriophages. Antimicrobial Agents and Chemotherapy 50:6, pages 2087-2097.
Crossref
Crossref